Essential Pharma acquires Reminyl oral capsules
Essential Pharma has completed the acquisition of Reminyl® oral capsules from Janssen Pharmaceutica NV, a Johnson & Johnson company. Reminyl®, a cholinesterase inhibitor, is an established central nervous system (CNS) drug indicated for the treatment …